Philadelphia Business Journal honors Shauna Itri among its “Best of the Bar”

Seeger Weiss LLP is proud to announce that partner Shauna Itri has been named to Philadelphia Business Journal’s 2020 “Best of the Bar,” which lists the city’s top 40 lawyers. Itri has been honored for her work in the practice of business litigation. For well over a decade, Itri has led litigation teams in complex […]

September 30, 2020

Shauna-Itri

Seeger Weiss LLP is proud to announce that partner Shauna Itri has been named to Philadelphia Business Journal’s 2020 “Best of the Bar,” which lists the city’s top 40 lawyers. Itri has been honored for her work in the practice of business litigation.

For well over a decade, Itri has led litigation teams in complex fraud cases in both state and federal courts. Itri’s nationwide practice has focused on representing plaintiffs in various settings — including securities and consumer class actions; antitrust; and cases involving patient harm. Itri also has extensive experience representing whistleblowers in False Claims Act lawsuits and other whistleblower programs throughout the United States.

Recently, Itri has been involved in several notable cases. In one, medical device company Covidien agreed to pay $13 million to resolve a False Claims Act lawsuit filed by Itri on behalf of her client, a former Covidien employee, who blew the whistle on a kickback scheme designed to defraud Medicare programs. In another False Claims Act lawsuit, genetics testing company Renaissance RX (or RenRX) agreed to pay $42.6 million to resolve six different whistleblower lawsuits that contained allegations of payments to providers in exchange for their ordering RenRX’s genetic tests, inappropriate payments to independent sales representatives which violated the anti-kickback statute, and lack of medical necessity of the genetic testing. Notably, RenRX also consented to a 25-year exclusion from all federal healthcare programs. “It’s pretty significant,” Itri said. “This is always an option CMS [Centers for Medicare and Medicaid Services] has in its arsenal but, in my experience, it’s rarely used. That said, it’s effective because exclusion from Medicare [represents] a significant loss of revenue.”

Philadelphia Business Journal’s “Best of the Bar” list is compiled by a panel of outside judges—former Philadelphia Bar Chancellor Debbie Gross, former Temple Law dean Carl Singley, and legal recruiting firm Mestel & Co. executive director Rona Sisson—who select lawyers who have distinguished themselves in their practice specialties. The is the 4th annual “Best of the Bar” list published by Philadelphia Business Journal.

No aspect of this advertisement has been approved by the Supreme Court of New Jersey or a court or authority of any jurisdiction.

Related News

March 12, 2026
Seeger Weiss Partner Parvin Aminolroaya and Counsel Max Kelly Appointed to Leadership Roles in GLP-1 NAION Products Liability Litigation

Seeger Weiss is proud to announce that Partner Parvin Aminolroaya has been appointed Co-Lead Counsel for Plaintiffs in the In Re: GLP-1 RAS Non-arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation and Counsel Max Kelly has been appointed to the Plaintiffs’ Executive Committee. The litigation involves claims that GLP-1 receptor agonist drugs including Ozempic, Wegovy, […]

Read More
February 18, 2026
Twelve Seeger Weiss Attorneys Named to The 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers Guide

Seeger Weiss is proud to announce that twelve Seeger Weiss attorneys have been selected for inclusion in the 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers guide. Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Steven Daroci, Scott Alan George, Shauna Itri, Diogenes P. Kekatos, Michael L. Rosenberg, Jennifer Scullion, […]

Read More
February 17, 2026
$7.25 Billion Nationwide Roundup / Glyphosate Class Action Settlement To Provide Compensation To Those Diagnosed With Non-Hodgkin Lymphoma After Exposure To Weedkiller

ST. LOUIS, MO – A proposed nationwide class-action settlement resolving claims that exposure to Roundup herbicides caused non-Hodgkin lymphoma (NHL) was filed today in the 22nd Judicial Circuit Court for the City of St. Louis, Missouri. The settlement would make up to $7.25 billion available to compensate individuals across the United States who were exposed […]

Read More